DEUCRAVACITINIB for Granuloma annulare: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 5 adverse event reports in the FDA FAERS database where DEUCRAVACITINIB was used for Granuloma annulare.

Most Reported Side Effects for DEUCRAVACITINIB

Side Effect	Reports	%	Deaths	Hosp.
Drug ineffective	228	9.6%	0	1
Acne	225	9.4%	0	1
Pruritus	187	7.8%	0	2
Rash	175	7.3%	0	0
Erythema	124	5.2%	0	2
Psoriasis	122	5.1%	0	2
Off label use	101	4.2%	1	6
Adverse event	74	3.1%	0	0
Mouth ulceration	72	3.0%	0	1
Folliculitis	65	2.7%	0	2
Headache	65	2.7%	0	0
Product dose omission issue	61	2.6%	0	0
Pain	60	2.5%	0	1
Skin burning sensation	60	2.5%	0	1
Diarrhoea	46	1.9%	1	3